• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

the axe is starting to fall my friends


<



http://www.inpharm.com/news/151056/novartis-close-uk-research-site

the cleanup starts from the UK this time. We'll be next very soon. Prepare yourselves and be brave. June here we come!

Just because they are closing a site in the UK, there is no reason deduce that anything may or may not follow in the US. These would be entirely independent events. And "be brave "? Please. Getting laid off from Novartis was the best thing that has happened in my professional life. You work for a miserable organization; when you get out, you will see that is true.